Volpara Health Technologies
Volpara Health Technologies Limited is a leading provider of breast imaging analytics and analysis products that improve clinical decision-making and the early detection of breast cancer. Every day, Volpara software helps clinicians better understand their patients and administrators better understand their practices.
Volpara Health Technologies Limited (formerly Matakina Technology Limited) is a research, development, and manufacturing company based in Wellington, New Zealand. With a diverse research team led by internationally recognized experts in medical physics, as well as proprietary medical imaging technology covered by multiple patents and trademarks, we apply science to the solving of clinical problems around the world.
Latest Media Releases
06/04/2017 09:01:00
Wellington, NZ, 5th April 2017: Volpara Health Technologies (“Volpara”; ASX:VHT), a digital health company focused on early detection of breast cancer by improving quality of screening, is…
03/03/2017 12:40:00
Wellington, NZ, 3rd March 2017: Volpara Health Technologies (“Volpara”; ASX:VHT), a digital health company focused on early detection of breast cancer by improving quality of screening, ha…
Latest News
Company Presentations /
by -
4 months ago
12 Jun 2018 - Volpara Health Technologies Limited (ASX:VHT) CEO, Dr Ralph Highnam presents on the rollout of the company's software in the US and how it is improving breast cancer …
Interviews /
by Jessica Amir -
4 months ago
12 Jun 2018 - Volpara Health Technologies Limited (ASX:VHT) CEO, Dr Ralph Highnam talks about the rollout of the company's software in the US and how it is improving breast cancer …
Market Reports /
by Jessica Amir -
11 months ago
13 Nov 2017 - Market Wrap: Sluggish start to the week with Westpac and ANZ going ex-div and IRESS being sold off. Fortescue Metals (ASX:FMG) issued a notice of termination to Tran…
Company Presentations /
by -
11 months ago
31 Oct 2017 - Volpara Health Technologies Limited (ASX:VHT) CEO, Dr Ralph Highnam, discusses the company's breast screening platform, the market opportunity and outlook.
Interviews /
by Jessica Amir -
11 months ago
30 Oct 2017 - Volpara Health Technologies (ASX:VHT) CEO, Dr. Ralph Highnam discusses its breast cancer screening technology, strategy and outlook.
Interviews /
by Jessica Amir -
A year ago
06 Jun 2017 - Volpara Health Technologies (ASX:VHT) CEO Dr Ralph Highnam talks about the company's growing customer base as it moves its business to a software as a service (SAS) m…
Interviews /
by Carolyn Herbert -
A year ago
29 March 2017 - Volpara Health Technologies (ASX:VHT) Non -Executive Director, Professor Sir Michael Brady talks about big data, machine learning and the benefits of image analysis…
Interviews /
by Carolyn Herbert -
A year ago
23 Feb 2017 - Volpara Health Technologies (ASX:VHT) Chief Commercial Officer, Mark Koeniguer talks about market reception to its products and its commercial strategy.
Interviews /
by Clive Tompkins -
A year ago
16 November 2016 - Volpara Health Technologies (ASX:VHT) CEO, Dr Ralph Highnam, discusses the impact of new US FDA breast-screening image requirements and how its VolparaEnterprise…
Company Presentations /
by Carolyn Herbert -
2 years ago
26 Sep 2016 - Volpara Health Technologies Ltd (ASX:VHT) Executive Director & CEO, Ralph Highnam, presents at the ASX CEO Sessions in Sydney.
Interviews /
by Carolyn Herbert -
2 years ago
26 Sep 2016 - Volpara Health Technologies (ASX:VHT), CEO Dr. Ralph Highnam discusses its breast cancer diagnosis products and growth plans.
Company Presentations /
by Carolyn Herbert -
2 years ago
12 Aug 2016 - Volpara Health Technologies (ASX:VHT): Chairman Roger Allen, CEO Ralph Highnam and Chief Commercial Officer Mark Koeniguer present at the 2016 AGM.
Interviews /
by David Chau -
2 years ago
02 Jun 2016 - Volpara Health Technologies (ASX:VHT) CEO & Executive Director, Dr Ralph Highnam talks about the highlights from FY16 results and outlook.
Interviews /
by Carolyn Herbert -
2 years ago
29 Apr 2016 - Volpara Health Technologies Limited (ASX:VHT) CEO and Executive Director Dr Ralph Highnam discusses the company's ASX listing and introduces its solution for the ear…
